Janeway lesions and Osler nodes represent classic peripheral cutaneous stigmata of infective endocarditis (IE), providing vital physical examination clues to underlying endocardial infection1,2. Janeway lesions manifest as non-tender, erythematous or hemorrhagic macular lesions predominantly located on the palms and soles, resulting from septic microembolization originating from cardiac valvular vegetations1,2. Conversely, Osler nodes present as painful, tender, violaceous subcutaneous nodules typically found on the pulp of the fingers and toes, driven primarily by localized immune-complex-mediated vasculitis1,2. Recognizing these distinct cutaneous manifestations assists clinicians in identifying systemic infection, guiding prompt blood cultures, echocardiography, and targeted antimicrobial therapy.

Etiology & Risk Factors

  • Microbial Etiologies: Most commonly caused by Gram-positive cocci, including Staphylococcus aureus (frequently associated with acute presentations and septic emboli like Janeway lesions), Streptococcus viridans (traditionally linked to subacute presentations and immune phenomena like Osler nodes), enterococci, and the HACEK group organisms3.
  • Underlying Structural Heart Disease: Pre-existing valvular abnormalities, mitral valve prolapse with regurgitation, calcific aortic stenosis, prosthetic heart valves, and congenital heart defects (e.g., ventricular septal defects, tetralogy of Fallot)3.
  • Iatrogenic & Lifestyle Risk Factors: Intravenous drug use (IVDU), presence of long-term indwelling central venous catheters, pacemaker or implantable cardioverter-defibrillator (ICD) leads, hemodialysis access, and chronic immunosuppression3.
  • Dental & Mucosal Portals: Poor oral hygiene, periodontal disease, and recent invasive dental or surgical procedures that facilitate transient bacteremia3.

Pathophysiology

The pathogenesis of both lesions originates from active infection of the endothelial surface of the heart, most frequently the cardiac valves. Turbulent blood flow or endothelial injury exposes extracellular matrix proteins, leading to the deposition of fibrin and platelets into sterile thrombi (non-bacterial thrombotic endocarditis). Subsequent transient bacteremia leads to microbial seeding of these thrombi, establishing infected valvular vegetations. From these friable intracardiac masses, micro-fragments detach and embolize into the systemic arterial circulation. Janeway lesions develop directly from septic microemboli that occlude small dermal arterioles and capillaries. The lodging of bacteria elicits localized microabscess formation, tissue necrosis, and capillary hemorrhage without significant initial inflammatory cell infiltration, explaining their non-tender nature. In contrast, Osler nodes arise from the deposition of circulating immune complexes within the microvasculature of the distal digits. These immune complexes fix complement, recruiting neutrophils and precipitating a localized Arthus-type hypersensitivity reaction (leukocytoclastic vasculitis). The resulting tissue edema and perineural irritation stimulate local nociceptors, producing the characteristic tenderness of Osler nodes.

Janeway lesions and Osler nodes — Pathophysiological Cascade & Clinical Flowchart 1 Valvular Endocardial Infection Transient bacteremia colonizes damaged heart valves, forming infected vegetations. 2 Microembolization & Immune Complex Deposition Septic microemboli detach from cardiac vegetations, while circulating immune complexes deposit in peripheral microvasculature. 3 Cutaneous & Subcutaneous Microvascular Injury Localized neutrophilic vascular invasion causes microabscesses (Janeway lesions) or immune-mediated leukocytoclastic vasculitis (Osler nodes). 4 Characteristic Peripheral Manifestations Development of painless erythematous macules on palms/soles (Janeway) vs. painful tender violaceous nodules on finger/toe pads (Osler). 5 Definitive Anticrobial Sterilization Eradication of endocardial infection via prolonged parenteral antibiotics combined with hemodynamic stabilization or surgical valve replacement.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically report a prolonged or acute systemic illness characterized by persistent low-grade or high-spiking fevers, chills, generalized fatigue, night sweats, anorexia, unintended weight loss, and dyspnea. A careful history often reveals recent dental procedures, intravascular catheter placement, or a history of intravenous drug use3.
  • Physical Examination & Named Clinical Signs:
    • Janeway Lesions: Small (1–4 mm), flat or slightly raised, painless erythematous, hemorrhagic, or maculopapular lesions distributed across the thenar and hypothenar eminences of the palms and the plantar surfaces of the feet. They blanch poorly and resolve spontaneously over days to weeks without scarring.
    • Osler Nodes: Small (2–15 mm), tender, raised, violaceous or pinkish subcutaneous nodules typically situated on the pads of the fingers and toes. They frequently present with a pale center and persist for several hours to days.
    • Other Associated Stigmata: Splinter hemorrhages beneath the nail beds, Roth spots (oval retinal hemorrhages with pale centers), petechiae on the conjunctiva and oral mucosa, and a new or changing regurgitant cardiac murmur heard upon auscultation.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationBlood cultures (at least three sets drawn from separate venipuncture sites over 24 hours prior to antibiotic initiation) demonstrating continuous bacteremia with typical organisms, paired with transthoracic echocardiography (TTE) followed by transesophageal echocardiography (TEE) to visualize valvular vegetations, abscesses, or new dehiscence.
Laboratory PanelElevated inflammatory markers (ESR, CRP), normocytic normochromic anemia of chronic disease, leukocytosis with a left shift (in acute presentations), microscopic hematuria, and proteinuria indicating immune complex-mediated glomerulonephritis.
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography to assess for pulmonary septic emboli (in right-sided endocarditis) or heart failure; cardiac CT or cardiac MRI for evaluating perivalvular extension, abscesses, or pseudoaneurysms; brain MRI if neurologic deficits suggest septic embolic stroke.
ECG / Histopathology / ProceduralElectrocardiogram (ECG) to monitor for new conduction delays or heart block indicating aortic root abscess formation; histopathologic examination of excised valvular tissue revealing dense microbial colonies within fibrin-platelet vegetations.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Modified Duke Criteria: Major CriteriaPositive blood cultures for typical microorganisms from 2 separate blood cultures, or persistently positive blood cultures, or single positive blood culture for Coxiella burnetii; evidence of endocardial involvement on echocardiography (oscillating intracardiac mass, abscess, new partial dehiscence of prosthetic valve, or new valvular regurgitation). Janeway lesions and Osler nodes count as minor criteria.
Modified Duke Criteria: Minor CriteriaPredisdisposing heart condition or IVDU; fever >38.0°C; vascular phenomena (major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway lesions); immunologic phenomena (glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor); microbiological evidence not meeting major criteria.
Definite IE Diagnostic ThresholdPathologic criteria (microorganisms demonstrated in vegetation, embolized vegetation, or intracardiac abscess) OR 2 major criteria, OR 1 major and 3 minor criteria, OR 5 minor criteria.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Systemic Lupus Erythematosus (Libman-Sacks Endocarditis)Non-infective sterile vegetations; patients typically present with multi-organ autoimmune involvement, positive antinuclear antibodies (ANA), anti-dsDNA, and negative blood cultures.
Disseminated GonococcemiaPresents with tenosynovitis, polyarthralgia, and painless pustular or vesicular skin lesions on distal extremities; blood cultures may be positive, but echocardiography shows no valvular vegetations.
Vasculitis (e.g., Polyarteritis Nodosa, ANCA-associated)Cutaneous nodules and purpura can mimic Osler or Janeway lesions; however, patients exhibit systemic inflammatory features, positive autoantibodies (ANCA), normal echocardiograms, and negative blood cultures.
Secondary Syphilis / Secondary Embolic PhenomenaPalmar and plantar macules/papules (luetic rash) can resemble Janeway lesions; differentiated by specific serological testing (VDRL/RPR, FTA-ABS) and absence of endocardial vegetations.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate hospital admission, continuous hemodynamic monitoring, and prompt evaluation for acute heart failure, cardiogenic shock, or embolic stroke. Avoid initiating empirical antibiotics until adequate blood culture sets are obtained unless the patient is hemodynamically unstable.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Empiric Coverage (Pending Cultures): Vancomycin (15–20 mg/kg IV every 8–12 hours, targeting trough levels of 15–20 mcg/mL) plus Ceftriaxone (2 g IV every 24 hours) or Gentamicin.
    • Methicillin-Susceptible Staph. Aureus (MSSA): Nafcillin or Oxacillin 2 g IV every 4 hours for 4–6 weeks.
    • Methicillin-Resistant Staph. Aureus (MRSA): Vancomycin 15–20 mg/kg IV every 8–12 hours or Daptomycin 6–10 mg/kg IV every 24 hours for 6 weeks.
    • Streptococci (Penicillin-Sensitive): Aqueous crystalline penicillin G 12–18 million units IV daily (administered in 4–6 divided doses) or Ceftriaxone 2 g IV every 24 hours for 4 weeks (monotherapy or combined with short-course gentamicin).
  • Surgical / Interventional Indications: Urgent or emergency cardiac surgery is indicated for refractory heart failure secondary to acute valvular regurgitation, annular or aortic abscess formation, persistent positive blood cultures after 7–10 days of appropriate antimicrobial therapy, fungal endocarditis, and prevention of recurrent embolic events when vegetation size exceeds 10 mm with mobile components.

Complications & Prognosis

  • Acute Complications: Destructive valvular regurgitation leading to acute decompensated heart failure, conduction blocks, myocardial abscesses, septic embolization to the central nervous system (stroke, brain abscess, mycotic aneurysm), spleen, kidneys, and extremities, as well as metastatic infection (osteomyelitis).
  • Prognostic Indicators: Overall mortality remains significant (15–30% in-hospital mortality). Poor prognostic factors include older age, prosthetic valve involvement, Staphylococcus aureus etiology, heart failure at presentation, neurological complications, and delayed initiation of appropriate antimicrobial or surgical therapy3.